Koneksa

Thank you, NYC! 🍎 We had the loveliest time with you all at #AWSNYC this week. A very special shoutout to our customer Koneksa for joining Jemiah Sius on stage to bring their story of managing 20M+ APM transactions a day to life. 📺 Learn more about how Koneksa fuels medical research with observability: https://lnkd.in/g4B3TcDE

The Amazon Web Services (AWS) Summit is underway today in New York, highlighting the latest advancements in #cloud technology as well as showcasing advanced technologies like #GenAI. Koneksa's DevOps Team Lead, Zachary Feldman, chatted with New Relic's Senior Director of Developer Relations, Jemiah Sius, in a session titled "Expert-level Problem-Solving for Engineers." Zach highlighted how his team at Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers to revolutionize drug development, utilizes the New Relic platform to ensure a secure and observable software solution. #AWSNYSummit #AWSSummit #AWS #NewYorkEvents #ProblemSolving #Engineers

🌟 Koneksa attended the 7th Annual Digital Biomarkers in Clinical Trials Summit at Roche HQ. Insights highlighted digital biomarkers' impact across multiple therapeutic areas, reducing sample sizes, and enhancing endpoint precision. Our CEO, Chris Benko, presented our work on a patient-centric prognostic biomarker for Sickle Cell Disease and our team showcased the latest Koneksa Platform. Strong progress in transforming clinical trials and improving treatment assessment! Read more here: https://lnkd.in/gW8ZB4X6 #patientsfirst #digitalbiomarkers #clinicaltrials #digital #panagorapharma #sicklecelldisease #digitalbiomarkersummit

📣 Streamlining Clinical Trials for Patients & Clinicians Through Digital Join our panel of #HealthtechLeaders as they discuss: ·  Co-creating a solution with patients and medical professionals ·  Scaling digital clinical trials solutions ·  Achieving diversity, equity, and inclusion in decentralized trials ·  Partnering for success- Is a unified digital clinical trial solution the answer? ·  Investing in clinical trial tech – investor perspectives 🎙 Hear from: ·  John Wagner, MD, PhD, Chief Medical Officer, Koneksa ·  Jodi Akin, Founding CEO, Hawthorne Effect, Inc. ·  Sarah Valentine, Partnerships Lead, Life Sciences, Digital Medicine Society (DiMe) ·  Ben Casavant, Co-Founder & CEO, Tasso, Inc. Find out more: https://lnkd.in/eZqJVQcM #LSXWorld 

Chris Benko from Koneksa sharing groundbreaking work on #sicklecell disease by working directly with patients, getting their feedback, organizing advisory boards and leveraging #DHTs to help identify digital signatures of disease #DigitalBiomarkersSummit

Tomorrow, June 26th, Koneksa's CEO Chris Benko will be presenting a case study on designing a “Patient Centric Prognostic Biomarker for Sickle Cell Disease” at the 7th Annual Digital Biomarker Summit in Basel. Learn more at https://lnkd.in/drySvksT #sicklecelldisease #patientsfirst #digitalbiomarkers #clinicaltrials #digital #panagorapharma #digitalbiomarkersummit

We are proud that Koneksa’s CSO, Elena Izmailova, will be a plenary speaker at a public workshop co-sponsored by FDA and Digital Medicine Society (DiMe) on "Using Patient-Generated Health Data (PGHD) in Medical Device Development: Case Examples of Implementation Throughout the Total Product Life Cycle." Join Elena and other industry leaders to hear patients, sponsors, regulators, and researchers share their perspectives on how using PGHD can help advance remote clinical trial data collection and support clinical outcome assessments. The deadline to register for this virtual workshop is June 25, 2024. https://lnkd.in/e_vjqdeH

What does it take to design a patient-centric prognostic biomarker for sickle cell disease? Attend the 7th Annual Digital Biomarker Summit in Basel on June 26th to listen to our CEO, Chris Benko’s session on the above topic as well as dive into the latest developments and applications of digital biomarkers in drug development and clinical trials. Chris will be joined by, Robert Ellis, Head of Biomarker Exploration Hiromasa Mori, VP, Neuroscience Business Unit Michael Pfluger, VP Sales Pooja Nandi, Scientific Product Manager #sicklecelldisease #patientsfirst #digitalbiomarkers #clinicaltrials #digital #panagorapharma #digitalbiomarkersummit

Koneksa is hiring its first Chief Business Officer! We are excited to share the details of this high impact position for a new member of our Executive Leadership Team. https://lnkd.in/ehSNWw2z

What is the  value of digital endpoints in clinical studies? Their potential is undeniable, the value is significant; and yet, widespread adoption remains a challenge. Koneksa is thrilled to be a part of the official launch of Digital Medicine Society (DiMe)'s new project, "Building the Business Case for Digital Endpoints.” Along with industry partners, we share in the vision that digital endpoints hold the potential to improve the design and execution of clinical trials, making them more patient-centric, data-driven, and adaptable to the evolving needs of clinical research. Learn more here, including signing up to stay up-to-date with this project and be among the first to access the project resources: https://lnkd.in/ej6YnfSi * * * Thank you to all of the collaborators Digital Medicine Society (DiMe), AbbVie, ActiGraph, Biofourmis, BlueSkeye AI, Brain & Mind ltd, CHEO, Chugai Pharma USA, Inc., COPD Foundation, Cosinuss GmbH, Critical Path Institute (C-Path), EVMS Medicine, Evinova, FDA, Genentech, Health Advances, Merck, Mitsubishi Tanabe Pharma America, Modality.AI, OmniScience, Regeneron, Roche, Sama Therapeutics, Sanofi, Seuss+, Strados Labs, SYSNAV Healthcare, Tech Doctor, Inc., TNO, Tufts Center for the Study of Drug Development, UChicago Medicine, VeriSIM Life, WKD.SMRT, Mobilise-D , Cumulus Neuroscience, Imperial College London